CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Intra-Cellular Therapies, Inc.

ITCI
N/A

Next catalyst

Phase 2March 2027

ITI-1284

Agitation Associated With Alzheimer's Dementia

Get an email about ITCI's next catalysts

Track Intra-Cellular Therapies (ITCI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 4 more upcoming events in our data (Phase 3 readout, Phase 2 readout).See the timeline

Catalyst Timeline

5 upcoming, 0 past

Phase 2Next

ITI-1284 Phase 2 Est. Readout

March 2027~ITI-1284705

Primary completion for ITI-1284 trial (NCT06480383) in Generalized Anxiety Disorder

Source
Phase 3

Lumateperone Phase 3 Est. Readout

April 2027~Lumateperone470

Primary completion for Lumateperone trial (NCT06372964) in Bipolar Depression

Source
Phase 3

Lumateperone low dose Phase 3 Est. Readout

Q2 2027~QLumateperone low dose160

Primary completion for Lumateperone low dose trial (NCT06690398) in Irritability Associated With Autism Spectrum Disorder

Source
Phase 3

Lumateperone high dose Phase 3 Est. Readout

Q2 2027~QLumateperone high dose160

Estimated primary completion for Lumateperone high dose trial (NCT06706674) in Irritability Associated With Autism Spectrum Disorder. Topline data typically follows completion by weeks to months.

Source
Phase 2

ITI-1284 Phase 2 Est. Readout

Q4 2027~QITI-1284570

Primary completion for ITI-1284 trial (NCT06701903) in Generalized Anxiety Disorder

Source

Market Overview

Stock performance and key metrics

NASDAQBiotechnology🇺🇸North America
Drug Pipeline

Frequently asked questions

What is in Intra-Cellular Therapies, Inc.'s drug pipeline?→

CatalystAlert tracks 12 drug candidates in Intra-Cellular Therapies, Inc.'s (ITCI) pipeline across Phase 3, Phase 2. Its lead program is ITI-1284 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Intra-Cellular Therapies, Inc.'s next FDA catalyst?→

Intra-Cellular Therapies, Inc.'s (ITCI) next tracked catalyst is a Phase 2 readout expected March 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ITCI biotech catalysts?→

Add ITCI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Intra-Cellular Therapies, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply